Turn Therapeutics (TTRX) Research & Development (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Research & Development of $109434.0 in Q1 2026, up 213.26% quarter-over-quarter from $34934.0 in Q4 2025, and up 1081.92% on a YoY basis from $9259.0 in Q1 2025.
Turn Therapeutics (TTRX) Research & Development (2024 - 2026) Analysis & Trends
Turn Therapeutics' Research & Development history runs 3 years deep, the most recent figure standing at $109434.0 for Q1 2026.
- In Q1 2026, Research & Development rose 1081.92% year-over-year to $109434.0; the TTM figure through Mar 2026 stood at $312326.0 (changed N/A YoY), while the FY2025 annual figure was $265570.0, up 7.97% from the prior year.
- Research & Development was $109434.0 for Q1 2026 at Turn Therapeutics, up from $34934.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $158699.0 in Q3 2025 to a low of $9259.0 in Q1 2025.
- Historically, Research & Development has averaged $79229.0 across 3 years, with a median of $72184.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Research & Development rose 3.53% in 2025, then surged 1081.92% in 2026.
- A 3-year view of Research & Development shows it stood at $9766.0 in 2024, then surged by 257.71% to $34934.0 in 2025, then soared by 213.26% to $109434.0 in 2026.
- The last three Research & Development figures came in at $109434.0 (Q1 2026), $34934.0 (Q4 2025), and $158699.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | 109,434.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,434.00 |
| Dec 31, 2025 | 34,934.00 |
| Sep 30, 2025 | 158,699.00 |
| Mar 31, 2025 | 9,259.00 |
| Dec 31, 2024 | 9,766.00 |
| Sep 30, 2024 | 153,282.00 |